Cargando…

Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders

Neuropsychiatric disorders, such as depression, bipolar disorder, schizophrenia, obsessive-compulsive disorder, and neurodevelopmental disorders such as autism spectrum disorder, are associated with significant illness burden. Accumulating evidence supports an association between these disorders and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sethi, Rickinder, Gómez-Coronado, Nieves, Walker, Adam J., Robertson, Oliver D’Arcy, Agustini, Bruno, Berk, Michael, Dodd, Seetal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738329/ https://www.ncbi.nlm.nih.gov/pubmed/31551825 http://dx.doi.org/10.3389/fpsyt.2019.00605

Ejemplares similares

Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
por: Westwell-Roper, Clara, et al.
Publicado: (2020)

Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0
por: Salagre, Estela, et al.
Publicado: (2018)

Biology of cyclooxygenase-2: An application in depression therapeutics
por: He, Ying, et al.
Publicado: (2022)

Expression of cyclooxygenase-2 (COX-2) in pituitary tumours
por: Sokołowski, Grzegorz, et al.
Publicado: (2012)

Neurobiology of Behavior—Influences of Neuropsychiatric Disorders on Neurobiology and Behavior
por: Fakhoury, Marc, et al.
Publicado: (2023)

The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment
por: Giménez-Palomo, Anna, et al.
Publicado: (2021)

Editorial: Placebo and Nocebo Effects in Psychiatry and Beyond
por: Weimer, Katja, et al.
Publicado: (2020)

Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
por: Kim, Sung-Wan, et al.
Publicado: (2019)

Integrated Neurobiology of Bipolar Disorder
por: Maletic, Vladimir, et al.
Publicado: (2014)

The changing relationship between health risk behaviors and depression among birth cohorts of Canadians 65+, 1994–2014
por: Yang, Guang, et al.
Publicado: (2022)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
por: Smith, Francine G., et al.
Publicado: (2012)

Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors
por: Ganduri, Vinutna, et al.
Publicado: (2022)

Neurobiological Approach of Catatonia and Treatment Perspectives
por: Ellul, Pierre, et al.
Publicado: (2015)

Editorial: Neurobiological Perspectives in Behavioral Addiction
por: Choi, Jung-Seok, et al.
Publicado: (2019)

Neurobiological Determinants of Tobacco Smoking in Schizophrenia
por: Lucatch, Aliya M., et al.
Publicado: (2018)

Editorial: The neurobiology of suicide: the ‘suicidal brain'
por: Hocaoglu, Cicek
Publicado: (2023)

Editorial: Unravelling the role of CB2r in neuropsychiatric diseases
por: Onaivi, Emmanuel S.
Publicado: (2023)

Pancreatic Stellate Cells (PSCs) express Cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs
por: Yoshida, Seiya, et al.
Publicado: (2005)

Does Gender Moderate the Relationship Between Chronic Pain and Substance Use Disorder? Insights From a National Canadian Population Survey
por: Su, Yingying, et al.
Publicado: (2022)

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
por: Ishiguro, Hiroki, et al.
Publicado: (2022)

Pathways Relating the Neurobiology of Attachment to Drug Addiction
por: Strathearn, Lane, et al.
Publicado: (2019)

Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair
por: Einhorn, Thomas A
Publicado: (2003)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2012)

Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
por: Rawat, Chitra, et al.
Publicado: (2019)

Bioactivity of dihydropyrimidinone derivatives as inhibitors of cyclooxygenase-2 (COX-2): an in silico approach
por: Haq, Kautsar Ul, et al.
Publicado: (2023)

Editorial: Autism Spectrum Disorders: Developmental Trajectories, Neurobiological Basis, Treatment Update, Volume 2
por: Canitano, Roberto, et al.
Publicado: (2020)

Nucleobindin Co-Localizes and Associates with Cyclooxygenase (COX)-2 in Human Neutrophils
por: Leclerc, Patrick, et al.
Publicado: (2008)

Editorial: Neurobiology and Cognition Across the Autism-Psychosis Spectrum
por: Sasson, Noah J., et al.
Publicado: (2021)

Editorial: Neurobiological Underpinnings of Bipolar Disorder and Its Treatment
por: Singh, Balwinder, et al.
Publicado: (2021)

Clinical Lycanthropy, Neurobiology, Culture: A Systematic Review
por: Guessoum, Sélim Benjamin, et al.
Publicado: (2021)

The Phenomenology and Neurobiology of Visual Distortions and Hallucinations in Schizophrenia: An Update
por: Silverstein, Steven M., et al.
Publicado: (2021)

Neurobiological Alterations in Females With PTSD: A Systematic Review
por: Eder-Moreau, Elizabeth, et al.
Publicado: (2022)

The neurobiology of functional neurological disorders characterised by impaired awareness
por: Milano, Beatrice Annunziata, et al.
Publicado: (2023)

Editorial: The heterogeneity of neuropsychiatric disorders
por: Wu, Zhao-Min, et al.
Publicado: (2023)

Cyclooxygenase in normal human tissues – is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?
por: Zidar, Nina, et al.
Publicado: (2009)

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2006)

Regional Differences in the Neuronal Expression of Cyclooxygenase-2 (COX-2) in the Newborn Pig Brain
por: Oláh, Orsolya, et al.
Publicado: (2012)

Reversible Suppression of Cyclooxygenase 2 (COX-2) Expression In Vivo by Inducible RNA Interference
por: Zaiss, Anne K., et al.
Publicado: (2014)

Transgenic expression of cyclooxygenase-2 (COX2) causes premature aging phenotypes in mice
por: Kim, Joohwee, et al.
Publicado: (2016)

The Search for Cyclooxygenase-2 (COX-2) Inhibitors for the Treatment of Inflammation Disease: An in-silico Study
por: Ruslin, Ruslin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k8f8ijkalu5ab04es8imul3mcb